World's Best Scientists 2026 revealed!
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
130
Citations
87888
World Ranking
2440
National Ranking
32

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Xavier Montalban is affiliated with the Autonomous University of Barcelona in Spain. Their research primarily focuses on the field of medicine, with substantial contributions to pathology and forensic medicine, neurology, immunology, oncology, and molecular biology.

The majority of their work centers around multiple sclerosis and related neurological and immunological disorders. Main topics covered in their research include multiple sclerosis research studies, peripheral neuropathies and disorders, chronic lymphocytic leukemia research, polyomavirus and related diseases, chronic myeloid leukemia treatments, acute lymphoblastic leukemia research, and rheumatoid arthritis research and therapies.

Frequent publication venues for Xavier Montalban include:

  • Neurology
  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • Neurology Perspectives
  • Neurology Neuroimmunology & Neuroinflammation

Among their recent published papers are:

  • Ofatumumab versus Teriflunomide in Multiple Sclerosis (2020) in New England Journal of Medicine
  • 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis (2021) in The Lancet Neurology
  • Multiple sclerosis progression: time for a new mechanism-driven framework (2022) in The Lancet Neurology
  • Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study (2020) in The Lancet Neurology
  • Role of B Cells in Multiple Sclerosis and Related Disorders (2020) in Annals of Neurology

Xavier Montalban has collaborated frequently with several scholars including Mar Tintoré, Jaume Sastre-Garriga, Manuel Comabella, Àlex Rovira, and Ludwig Kappos. These collaborations reflect a sustained engagement with a network of researchers active in neurology and immunology.

Their research contributions encompass 704 publications in medicine, of which a significant number address specialized subfields: 256 in pathology and forensic medicine, 89 in neurology, 64 in immunology, 60 in oncology, and 55 in molecular biology.

Best Publications

  • Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

    Chris H Polman;Stephen C Reingold;Brenda Banwell;Michel Clanet

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

    Jeffrey A. Cohen;Frederik Barkhof;Giancarlo Comi;Hans Peter Hartung

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis

    Ludwig Kappos;Jack Antel;Giancarlo Comi;Xavier Montalban

  • Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity

    R. H.S.R. Roxburgh;S. R. Seaman;T. Masterman;A. E. Hensiek

  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

    X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

  • MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

    Massimo Filippi;Maria Assunta Rocca;Olga Ciccarelli;Olga Ciccarelli;Nicola De Stefano

  • Differential diagnosis of suspected multiple sclerosis: a consensus approach

    D. H. Miller;B. G. Weinshenker;M. Filippi;B. L. Banwell

  • Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

    David Miller;Frederik Barkhof;Xavier Montalban;Alan Thompson

  • Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

    L. Kappos;C.H. Polman;M.S. Freedman;G. Edan

  • Isolated demyelinating syndromes : Comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis

    Mar Tintoré;Alex Rovira;Maria J. Martínez;Jordi Rio

  • EFNS guidelines on diagnosis and management of neuromyelitis optica

    J. Sellner;M. Boggild;M. Clanet;R.Q. Hintzen

  • Vitamin D as an early predictor of multiple sclerosis activity and progression.

    Alberto Ascherio;Kassandra L. Munger;Rick White;Karl Köchert

  • Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

    Ludwig Kappos;Mark S Freedman;Chris H Polman;Gilles Edan

  • Primary progressive multiple sclerosis.

    A. J. Thompson;C. H. Polman;D. H. Miller;W. I. Mcdonald

  • Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

    G. Comi;V. Martinelli;M. Rodegher;L. Moiola

Frequent Co-Authors

Manuel Comabella
Manuel Comabella Vall d'Hebron Institut de Recerca
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Frederik Barkhof
Frederik Barkhof University College London
Alex Rovira
Alex Rovira Autonomous University of Barcelona
Massimo Filippi
Massimo Filippi Vita-Salute San Raffaele University
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Jerry S. Wolinsky
Jerry S. Wolinsky The University of Texas Health Science Center at Houston
Mark S. Freedman
Mark S. Freedman Ottawa Hospital
Alan J. Thompson
Alan J. Thompson University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond a traditional MD, aspiring healthcare professionals can explore a variety of alternative online degrees that open up rewarding career options in medicine and allied health fields. Specializing in healthcare management is a popular choice; there are many online mha programs affordable enough for students mindful of budget concerns, preparing graduates for leadership roles in hospitals and clinics.

Those interested in advanced nursing might consider cheap online dnp programs to become doctorally prepared nurse leaders or practitioners. Pharmacy is another high-demand field—an online pharmd program can open the door to roles in clinical pharmacy, research, or pharmaceutical administration.

The rise of digital health creates opportunities in information technology; a health informatics degree equips graduates to manage electronic health records and support medical decision-making. By choosing these flexible, online pathways, students can advance their careers in healthcare without relocating or interrupting current employment.

Best Scientists Citing Xavier Montalban

Trending Scientists

Recently Published Articles